Literature DB >> 16907

Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

A Abuchowski, J R McCoy, N C Palczuk, T van Es, F F Davis.   

Abstract

Methoxypolyethylene glycols of 1900 daltons (PEG-1900) or 5000 daltons (PEG-5000) were covalently attached to bovine liver catalase using 2,4,6-trichloro-s-triazine as the coupling agent. Rabbits were immunized by the intravenous and intramuscular routes with catalase modified by covalent attachment of PEG-1900 to 43% of the amino groups (PEG-1900-catalase). The intravenous antiserum did not yield detectable antibodies against PEG-1900-catalase or native catalase, as determined by Ouchterlony and complement fixation methods, whereas the intramuscular antiserum contained antibodies to both PEG-1900-catalase and catalase. PEG-1900 did not react with either antiserum. Catalase was prepared in which PEG-5000 was attached to 40% of the amino groups (PEG-5000-catalase). This catalase preparation did not react with either antiserum. PEG-1900-catalase retained 93% of its enzymatic activity; PEG-5000-catalase retained 95%. PEG-5000-catalase resisted digestion by trypsin, chymotrypsin, and a protease from Streptomyces griseus. PEG-1900-catalase and PEG-5000-catalase exhibited enhanced circulating lives in the blood of acatalasemic mice during repetitive intravenous injections. No evidence was seen of an immune response to injections of the modified enzymes. Mice injected repetitively with PEG-5000-catalase remained immune competent for unmodieied catalase, and no evidence of tissue or organ damage was seen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16907

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  178 in total

1.  Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.

Authors:  Yashveer Singh; Dayuan Gao; Zichao Gu; Shike Li; Stanley Stein; Patrick J Sinko
Journal:  Mol Pharm       Date:  2011-11-22       Impact factor: 4.939

Review 2.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

Review 3.  Enzyme stabilization: state of the art.

Authors:  L Gianfreda; M R Scarfi
Journal:  Mol Cell Biochem       Date:  1991-02-02       Impact factor: 3.396

4.  Drug development: Longer-lived proteins.

Authors:  Jeffrey A Hubbell
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

Review 5.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

6.  Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats.

Authors:  Yoshihiro Miyaji; Yuji Kasuya; Yoshitake Furuta; Atsushi Kurihara; Masayuki Takahashi; Ken-Ichi Ogawara; Takashi Izumi; Osamu Okazaki; Kazutaka Higaki
Journal:  Pharm Res       Date:  2012-06-23       Impact factor: 4.200

7.  Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MS.

Authors:  Hongyan Li; Mark J Rose; Jerry Ryan Holder; Marie Wright; Les P Miranda; Christopher A James
Journal:  J Am Soc Mass Spectrom       Date:  2011-06-23       Impact factor: 3.109

Review 8.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

Review 9.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

10.  Loading PEG-catalase into filamentous and spherical polymer nanocarriers.

Authors:  Eric A Simone; Thomas D Dziubla; Evguenia Arguiri; Vanessa Vardon; Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Vladimir R Muzykantov
Journal:  Pharm Res       Date:  2008-10-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.